Internet-based treatment of depressive symptoms in tumor patients.

Recruiting

• Conditions: low-grade glioma; low-grade hematological malignancies (non-Hodgkin lymphoma, chronic lymphocytic leukemia); depression

• Registration Number: NL-OMON27351
• Lead Sponsor: VU University Medical Center

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

1. >18 years of age;

2. Presence of either low-grade glioma (grade II) or low-grade hematological malignancies (NHL or CLL);

Exclusion Criteria

Major depression, no depressive symptoms, or suicidal intent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in depressive symptoms as measured by the Center for Epidemiological Studies Depression Scale (CES-D).

Secondary Outcome Measures

Name	Time	Method
Quality of life, symptoms of fatigue, cognitive functioning and variables that may predict outcome (working alliance between coach and patient, client satisfaction, problem-solving skills).